Corazon (Corsee) D. Sanders is Director of BeiGene, Ltd.. Currently has a direct ownership of 0 shares of BGNE, which is worth approximately $0. The most recent transaction as insider was on Jun 23, 2023, when has been sold 578 shares (American Depositary Shares) at a price of $181.7 per share, resulting in proceeds of $105,022. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Corazon (Corsee) D. Sanders Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2023
SELL
Open market or private sale
$105,022 $181.7 p/Share
578 Reduced 100.0%
0 American Depositary Sh...
Jun 15 2023
BUY
Grant, award, or other acquisition
-
12,922 Added 25.67%
37,414 Ordinary Shares
Jun 22 2022
BUY
Grant, award, or other acquisition
-
16,692 Added 40.53%
24,492 Ordinary Shares
Jun 16 2021
BUY
Grant, award, or other acquisition
-
7,800 Added 50.0%
7,800 Ordinary Shares

Also insider at

MTEM
Molecular Templates, Inc. Healthcare
RARE
Ultragenyx Pharmaceutical Inc. Healthcare
C(D

Corazon (Corsee) D. Sanders

Director
Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Track Activities on BGNE